Blue Dogs Endorse Bill to Prevent Dramatic Drug Price Hikes
Washington – Today, while the House Oversight Committee holds a bipartisan hearing with officials from Mylan, titled “Reviewing the Rising Price of EpiPens,” the Blue Dog Coalition endorsed a bill that could prevent dramatic price hikes like that of the EpiPen. H.R. 4784, the Lower Drug Costs Through Competition Act helps streamline the FDA approval process on generic drugs, and encourages competition by providing incentives for more generics to come to the market.